NEXT
Sign in to follow

The Legal Intelligencer

Under Fire, Ozempic Lawyers Add Two 'Team Players' to Proposed Leadership

Plaintiffs lawyers who assembled a proposed leadership team in Ozempic lawsuits fired back at the accusation that they excluded attorneys—then added two more lawyers to their proposed team.
5 minute read

Law.com

Despite Call for Civility, 'Squabbles Among Counsel' Emerge Over Ozempic Leadership

Plaintiffs lawyers in the Ozempic multidistrict litigation organized a leadership team of 30 attorneys, but one Florida attorney objected to the proposed slate, which she says appears to be composed of 'repeat players.'
5 minute read

The Legal Intelligencer

'How Can It Be Enough?': Thousands Have Agreed to the Risperdal Settlement. A Few Holdouts Remain

According to attorneys leading the litigation, more than 5,600 have agreed to the settlement, which is about 94% of the potential 6,000 claims for the bulk settlement. The lawyers said 99.9% of claimants have chosen to accept their settlement offers.
12 minute read

New Jersey Law Journal

McCarter & English File Patent Infringement Suit on Behalf of Merck, Others Over Migraine Medication Ubrelvy

This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide.
3 minute read

The Legal Intelligencer

Up to $1.1 Billion: Inside the Settlement Resolving Most of Philadelphia's Risperdal Cases

According to settlement records, the settlement's group expenses were $33 million, with additional costs expected to be incurred.
7 minute read

The Legal Intelligencer

Nearly Half of Philadelphia's Mass Tort Programs Are on Track to Close This Year

"Within the next several months, the court will be closing the Risperdal, Essure and Elmiron mass tort programs, as the lawyers and self-represented parties work through the remaining cases on the docket," Judge Joshua Roberts, head of the Philadelphia Court of Common Pleas Complex Litigation Center, said.
4 minute read

New Jersey Law Journal

Kirkland & Ellis Hired for Big Pharma Antitrust Suit

A 2020 verdict allowed Teva and other companies to produce generic versions of Vascepa. But Teva allegedly had to scale back its launch because of an inability to obtain the key ingredient, the suit said.
4 minute read

Law.com

Opioid Judge Rejects DQ Motion, But Cautions Motley Rice: 'The Court Frowns'

U.S. District Judge Dan Polster on Monday declined to disqualify Motley Rice from dozens of opioid cases, but said he was "very uncomfortable" with its government client arrangements.
5 minute read

Law.com

Another Defendant Says Motley Rice Should Be Disqualified From Opioid Litigation

Express Scripts Inc., a pharmacy benefit manager facing upcoming bellwether trials over the opioid crisis, filed a March 13 brief referencing a subpoena that Motley Rice member Linda Singer sent to the company on behalf of the city of Chicago.
4 minute read

Law.com

Social Media Ads Inject New Angle in Ozempic Cases: 'It's Going to Be a Huge Focus'

The proliferation of advertising on social media for Ozempic and related drugs will be a key part of the lawsuits against Novo Nordisk and Eli Lilly.
6 minute read

TRENDING STORIES

Law Pro Logo

Featured Firms

Law Offices of Gary Martin Hays & Associates, P.C.

(470) 294-1674

Law Offices of Mark E. Salomone

(857) 444-6468

Smith & Hassler

(713) 739-1250

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Why Are So Many Law Firms Suddenly Embracing Digital Transformation?

    Brought to you by AllRize

    Download Now

  • 2025 State Legislative Sessions

    Brought to you by LexisNexis®

    Download Now

  • Retention & Online Reputation for Law Firms: 2025 Guide

    Brought to you by Amazing Workplace, Inc.

    Download Now

  • Europe's Escalating Regulatory Framework: Mapping Efforts to Mitigate Supply Chain Risks

    Brought to you by LRN

    Download Now